Intol, Jessa Mae C.

HRN: 21-27-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2022
CEFUROXIME 500MG (TAB)
04/19/2022
04/25/2022
PO
500mg
BID X 7 Days
WBC: 14.4; S/p LTCS Secondary To Placenta Previa
Waiting Final Action 
06/25/2023
CEFUROXIME 1.5GM (VIAL)
06/26/2023
06/26/2023
IV
1.5gm
Prior OR
Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: